文献速递乳腺US

探索光声成像在鉴别乳腺良恶性肿块中的效用:第二代研究

Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses: Gen 2 Study.
PubMed 文献 · Acad Radiol · 2024-10-19

这项前瞻性单臂非随机研究在单一研究中心纳入38例可触及肿块和/或影像异常患者,评估第二代Imagio®系统的独立内部超声与光声/超声双模探头。在23例有SenoGram®预测恶性概率及病理结果的患者中,以SenoGram®预测假阴性率≤2%为阈值,敏感度为100.0%(9/9),特异度为64.3%(9/14);在98%固定敏感度下,光声/超声联合SenoGram®的特异度为100.0%,而独立内部超声为0.0%。结论认为将结构与形态结合可在真实世界中提高特异度而不降低敏感度。

要点

  • 光声/超声联合SenoGram®在98%固定敏感度下特异度为100.0%,独立内部超声为0.0%。
  • 以SenoGram®预测假阴性率≤2%为阈值,敏感度100.0%(9/9),特异度64.3%(9/14)。
  • 本研究为第二代Imagio®系统上市后修改的临床可接受性评估。

核心结论

  • 将结构与形态结合可在真实世界中提高特异度而不降低敏感度。

研究设计与样本

  • 前瞻性、单臂、非随机研究,纳入38例可触及肿块和/或影像异常患者,在单一研究中心进行,使用第二代Imagio®系统(型号9100、8101)对乳腺及必要时腋窝淋巴结成像。

诊断标准与关键数值

  • 在23例有SenoGram®预测恶性概率及病理结果的患者中,以SenoGram®预测假阴性率≤2%为阈值,敏感度为100.0%(9/9),置信区间(66.4%,100.0%)。
  • 在23例有SenoGram®预测恶性概率及病理结果的患者中,以SenoGram®预测假阴性率≤2%为阈值,特异度为64.3%(9/14),置信区间(35.1%,87.2%)。
  • 在98%固定敏感度下,光声/超声联合SenoGram®的特异度为100.0%,独立内部超声为0.0%,绝对增益为100.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The combination of functional biologic data and imaging appearance has the potential to add diagnostic information to help the radiologist evaluate breast masses in an efficient, effective, and cost-conscious manner. This is the first clinical evaluation of the Gen 2(Model 9100, 8101) Imagio® System to assess image quality with both the stand-alone internal ultrasound (IUS), ultrasound-only transducer, and the Optoacoustic/Ultrasound (OA/US) duplex probe (1,2). This study assesses palpable and non-palpable breast abnormalities in patients who are referred for diagnostic breast ultrasound work-up. This study is intended to confirm the clinical acceptability of modifications made to the Imagio® System ultrasound component following Premarket Approval (PMA) of the Imagio® Gen 1 version.

MATERIALS AND METHODS: This prospective, single-arm, non-randomized study included 38 patients presenting with a palpable lump and/or imaging abnormality detected at a single investigational site. Each patient had the breast, and if indicated, the axillary lymph nodes imaged with the Gen 2 Imagio® system.

RESULTS: For patients with SenoGram®-predicted Likelihood of Malignancy (LOM) and pathology available (N = 23), observed sensitivity was 100.0% (9/9) with a confidence interval of (66.4%, 100.0%), using a SenoGram®-predicted False Negative Rate (FNR) cut-off of ≤ 2%. Observed specificity was 64.3% (9/14) (Confidence Interval: 35.1%, 87.2%), using a SenoGram®-predicted FNR cut-off of ≤ 2%. At 98% fixed sensitivity, the specificity (fSp) for OA/US + SG was 100.0% while it was 0.0% for IUS. The absolute gain in fSp was 100.0%.

CONCLUSION: Combining structure with morphology can increase specificity without decreasing sensitivity in a real-world setting.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Ghannam S, Koneru V, Karabon P, et al. Exploring the Utility of Optoacoustic Imaging in Differentiation of Benign and Malignant Breast Masses: Gen 2 Study. Acad Radiol. 2024. PMID: 39426913. doi:10.1016/j.acra.2024.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。